Global Transplant Diagnostics Market 2016-2020
SKU ID :TNV-10289932 | Published Date: 20-May-2016 | No. of pages: 81Description
TOC
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
• Global transplant diagnostics market by molecular assays
• Global transplant diagnostics market by non-molecular assays
PART 06: Market segmentation by screening
• Pre-transplant diagnostics
• Post-transplant diagnostics
PART 07: Market segmentation by product
• Reagents and consumables
• Instruments
PART 08: Market segmentation by end-user
PART 09: Market segmentation by application
• Stem cell transplantation
• Organ transplantation
PART 10: Geographical segmentation
• Transplant diagnostics market in Americas
• Transplant diagnostics market in EMEA
• Transplant diagnostics market in APAC
PART 11: Market drivers
• Prevalence of chronic diseases
• Public awareness of organ donation
• Growth opportunities in emerging markets
PART 12: Impact of drivers
PART 13: Market challenges
• Unfavorable reimbursement scenario
• Limited technical expertise
• High cost of transplant diagnostics
PART 14: Impact of drivers and challenges
PART 15: Market trends
• Advances in technology
• Government initiatives
• Product approvals and launches
• Increase in M&A
PART 16: Vendor landscape
• Competitive scenario
PART 17: Major vendors
• Bio-Rad Laboratories
• CareDx
• Illumina
• Immucor
• Linkage Biosciences
• Thermo Fisher Scientific
• Other prominent vendors
PART 18: Appendix
• List of abbreviations
PART 19: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Types of HLA testing used to determine compatibility
Exhibit 03: Global transplant diagnostics market 2015-2020 ($ millions)
Exhibit 04: Five forces analysis
Exhibit 05: Global transplant diagnostics market segmentation by technique
Exhibit 06: Global transplant diagnostics market segmentation by technique 2015
Exhibit 07: Global transplant diagnostics market segmentation by technique 2020
Exhibit 08: PCR techniques: Advantages and disadvantages
Exhibit 09: Global transplant diagnostics market by molecular assays 2015-2020 ($ millions)
Exhibit 10: Global transplant diagnostics market by non-molecular assays 2015-2020 ($ millions)
Exhibit 11: Global transplant diagnostics market segmentation by screening 2015
Exhibit 12: Global transplant diagnostics market segmentation by screening 2020
Exhibit 13: Overview of pre- and post-transplant diagnosis
Exhibit 14: Global pre-transplant diagnostics market 2015-2020 ($ millions)
Exhibit 15: Global post-transplant diagnostics market 2015-2020 ($ millions)
Exhibit 16: Some reagents, consumables, and instruments available commercially
Exhibit 17: Global transplant diagnostics market by product 2015
Exhibit 18: Global transplant diagnostics market by product 2020
Exhibit 19: Global transplant diagnostics market segmentation by end-user 2015
Exhibit 20: Global transplant diagnostics market segmentation by end-user 2020
Exhibit 21: Global transplant diagnostics market segmentation by application
Exhibit 22: Global transplant diagnostics market segmentation by organ transplantation 2015
Exhibit 23: Global transplant diagnostics market segmentation by organ transplantation 2020
Exhibit 24: Deceased donors for different organs 2015
Exhibit 25: Living donors for different organs 2015
Exhibit 26: Global transplant diagnostics market segmentation by geography 2015
Exhibit 27: Global transplant diagnostics market segmentation by geography 2020
Exhibit 28: Global transplant diagnostics market segmentation by geography 2015-2020
Exhibit 29: Transplant diagnostics market in Americas 2015-2020 ($ millions)
Exhibit 30: Transplant diagnostics market in EMEA 2015-2020 ($ millions)
Exhibit 31: Transplant diagnostics market in APAC 2015-2020 ($ millions)
Exhibit 32: Impact of drivers
Exhibit 33: Price of sequencers of different companies
Exhibit 34: Impact of drivers and challenges
Exhibit 35: Bio-Rad Laboratories: Product portfolio
Exhibit 36: Bio-Rad Laboratories: Revenue of clinical diagnostics segment 2013-2015 ($ billions)
Exhibit 37: Bio-Rad Laboratories: Key takeaways
Exhibit 38: CareDx: Product portfolio
Exhibit 39: CareDx: AlloSure clinical studies
Exhibit 40: CareDx: Key takeaways
Exhibit 41: Illumina: Product portfolio
Exhibit 42: Illumina: Key takeaways
Exhibit 43: Immucor: Product portfolio
Exhibit 44: Immucor: Revenue of transplant and molecular segment 2013-2015 ($ millions)
Exhibit 45: Immucor: Key takeaways
Exhibit 46: Linkage Biosciences: Product portfolio
Exhibit 47: Linkage Biosciences: Key takeaways
Exhibit 48: Thermo Fisher Scientific: Product portfolio
Exhibit 49: Thermo Fisher Scientific: Revenue of specialty diagnostics segment 2013-2015 ($ billions)
Exhibit 50: Thermo Fisher Scientific: Key takeaways
Exhibit 51: Other prominent vendors
Tables & Figures
Companies
Bio-Rad Laboratories, CareDx, Illumina, Immucor, Linkage Biosciences, Thermo Fisher Scientific, Abbott Laboratories, Becton Dickinson, Danaher, F. Hoffmann-La Roche, HistoGenetics, Ortho Clinical Diagnostics, Oxford Immunotec, Qiagen, Siemens, Sigma-Aldrich, Tosoh Bioscience.
- PRICE
-
$2500$4000